Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Engraftment and Measurable Residual Disease Monitoring after Hematopoietic Stem Cell Transplantation

2 Feb 2024

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Hematopoietic Stem Cell Transplantation
Share to Renal Transplantation Outcomes and Treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 38307253
DOI: 10.1016/j.jmoldx.2024.01.007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Engraftment and Measurable Residual Disease Monitoring after Hematopoietic Stem Cell TransplantationPMID 38307253Read ↗

B-cell reconstitution after allogeneic SCT impairs minimal residual disease monitoring in children with ALLSemantic proximity Read ↗

Prognostic value of measurable residual disease monitoring by next-generation sequencing before and after allogeneic hematopoietic cell transplantation in acute myeloid leukemia.Semantic proximity Read ↗

Importance of measurable residual disease in the outcome of adults with acute lymphoblastic leukemia after allogeneic stem cell transplantation: Long follow-up analysis from a single transplant centerSemantic proximity Read ↗

Measurable residual disease in chronic myeloid leukemiaSemantic proximity Read ↗

Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or RelapseSemantic proximity Read ↗

Long-term observation reveals high-frequency engraftment of human acute myeloid leukemia in immunodeficient miceSemantic proximity Read ↗

Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profilingSemantic proximity Read ↗

Measurable residual disease monitoring by ddPCR in the early posttransplant period complements the traditional MFC method to predict relapse after HSCT in AML/MDS: a multicenter retrospective study.Semantic proximity Read ↗

Minimal residual disease diagnostics in myeloid malignancies in the post transplant period.Semantic proximity Read ↗

Inter-Laboratory Comparison of Chronic Myeloid Leukemia Minimal Residual Disease MonitoringSemantic proximity Read ↗

Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspectsSemantic proximity Read ↗

Should minimal residual disease monitoring be the standard of care for all patients with acute promyelocytic leukemia?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.